Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.3 USD | -0.43% | +2.14% | -4.77% |
03/05 | Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate | MT |
03/05 | J&J: to present advances in retinal diseases | CF |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- MarketScreener Strategies